Showing results (71-80 of 87) with videos related to
Sort By:
Pageof 9
Leukemia & Lymphoma|March 9, 2017
A phase 1 trial of the HDAC inhibitor AR-42 in patients with multiple myeloma and T- and B-cell lymphomasDouglas W Sborov, Alessandro Canella, Erinn M Hade, et al.Journal of Cellular Physiology|March 12, 2020
Requirement of GTP binding for TIF-90-regulated ribosomal RNA synthesis and oncogenic activities in human colon cancer cellsDang Quan Nguyen, Dinh Hoa Hoang, Michael Nelson, et al.Journal of Hematology & Oncology|August 14, 2024
IL1RAP-specific T cell engager depletes acute myeloid leukemia stem cellsYi Zhang, Miso Park, Lucy Y Ghoda, et al.Blood|February 23, 2024
A CD38-directed, single-chain T-cell engager targets leukemia stem cells through IFN-γ-induced CD38 expressionMariam Murtadha, Miso Park, Yinghui Zhu, et al.The New England Journal of Medicine|October 28, 2005
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemiaGeorge Adrian Calin, Manuela Ferracin, Amelia Cimmino, et al.Transplantation and Cellular Therapy|May 23, 2022
Proceedings from the Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Immune and Cellular Therapy in Multiple MyelomaSarah A Holstein, Fotis Asimakopoulos, Abdel Kareem Azab, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2011
Phase I trial of lenalidomide and CCI-779 in patients with relapsed multiple myeloma: evidence for lenalidomide-CCI-779 interaction via P-glycoproteinCraig C Hofmeister, Xiaoxia Yang, Flavia Pichiorri, et al.Blood Advances|October 23, 2020
Identifying CD38+ cells in patients with multiple myeloma: first-in-human imaging using copper-64-labeled daratumumabAmrita Krishnan, Vikram Adhikarla, Erasmus K Poku, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2016
BAI1 Orchestrates Macrophage Inflammatory Response to HSV Infection-Implications for Oncolytic Viral TherapyChelsea Bolyard, W Hans Meisen, Yeshavanth Banasavadi-Siddegowda, et al.JCI Insight|January 19, 2021
CD84 is a regulator of the immunosuppressive microenvironment in multiple myelomaHadas Lewinsky, Emine G Gunes, Keren David, et al.Pageof 9